Circassia Pharmaceuticals Plc Total Voting Rights (4126E)

TIDMCIR

RNS Number : 4126E

Circassia Pharmaceuticals Plc

28 February 2020

For immediate release

Circassia Pharmaceuticals plc

Total Voting Rights Update

28(th) February 2020

In accordance with the requirements of the FCA's Disclosure and Transparency Rule 5.6.1, Circassia Pharmaceuticals plc ("Circassia" or "the Company") (LSE: CIR) confirms that the Company's issued share capital consists of 375,210,543 ordinary shares of 0.08p each in issue, each with equal voting rights. No shares are held in treasury.

The above figure may be used by shareholders as the denominator for the calculations by which they will determine whether they are required to notify their interest, or a change to their interest, in the Company under the FCA's Disclosure Guidance and Transparency Rules .

-Ends-

 
 For further information, please contact: 
 
   Circassia Pharmaceuticals plc 
   Michael Roller, Company Secretary      +44 (0) 1865 405560

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

TVREAXAXAFNEEFA

(END) Dow Jones Newswires

February 28, 2020 02:00 ET (07:00 GMT)

Circassia (LSE:CIR)
Historical Stock Chart
From Apr 2024 to May 2024